Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination

Multiple factors may be associated with immune responses to SARS-CoV-2 vaccines. Factors potentially related to magnitude and durability of response include age, time, and vaccine reactogenicity. This study analyzed SARS-CoV-2 IgG spike antibody responses following the second dose of vaccine in heal...

Full description

Bibliographic Details
Main Authors: Jane A. Dickerson, Janet A. Englund, Xing Wang, Julie C. Brown, Danielle M. Zerr, Bonnie Strelitz, Eileen J. Klein
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/4/601
_version_ 1797434183831781376
author Jane A. Dickerson
Janet A. Englund
Xing Wang
Julie C. Brown
Danielle M. Zerr
Bonnie Strelitz
Eileen J. Klein
author_facet Jane A. Dickerson
Janet A. Englund
Xing Wang
Julie C. Brown
Danielle M. Zerr
Bonnie Strelitz
Eileen J. Klein
author_sort Jane A. Dickerson
collection DOAJ
description Multiple factors may be associated with immune responses to SARS-CoV-2 vaccines. Factors potentially related to magnitude and durability of response include age, time, and vaccine reactogenicity. This study analyzed SARS-CoV-2 IgG spike antibody responses following the second dose of vaccine in healthcare workers (HCWs). Data were collected from participants enrolled in a longitudinal SARS-CoV-2 serology study over a 12-month period. Participants completed a survey documenting symptoms post-vaccination. Serum specimens were tested for SARS-CoV-2 IgG antibodies using the Abbott Architect AdvisdeDx SARS-CoV-2 IgGII assay. Antibody levels were compared against time from second vaccine dose, and symptoms following vaccination. Altogether, 335 women (86.6%) and 52 men (13.4%) participated. Median age was 37 years (IQR 30-43). Overall median antibody level was 2150.80 [1246.12, 3556.98] AU/mL (IQR). Age was not associated with antibody concentration (<i>p</i>-value = 0.10). Higher antibody responses (2253 AU/mL vs. 1506 AU/mL; <i>p</i> = 0.008) were found in HCWs with one or more symptoms after the second dose of the vaccine (n = 311). Antibody responses persisted throughout the study period post-vaccination; statistically significant decreases in antibody responses were observed over time (<i>p</i> < 0.001). Higher antibody response was associated with reactogenicity post-vaccine. Age and sex were not associated with higher antibody responses.
first_indexed 2024-03-09T10:28:35Z
format Article
id doaj.art-d537c027a7be49dfb1dedee404aba1da
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T10:28:35Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-d537c027a7be49dfb1dedee404aba1da2023-12-01T21:30:39ZengMDPI AGVaccines2076-393X2022-04-0110460110.3390/vaccines10040601Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-VaccinationJane A. Dickerson0Janet A. Englund1Xing Wang2Julie C. Brown3Danielle M. Zerr4Bonnie Strelitz5Eileen J. Klein6Seattle Children’s Research Institute, Seattle, WA 98145, USASeattle Children’s Research Institute, Seattle, WA 98145, USASeattle Children’s Research Institute, Seattle, WA 98145, USASeattle Children’s Research Institute, Seattle, WA 98145, USASeattle Children’s Research Institute, Seattle, WA 98145, USASeattle Children’s Research Institute, Seattle, WA 98145, USASeattle Children’s Research Institute, Seattle, WA 98145, USAMultiple factors may be associated with immune responses to SARS-CoV-2 vaccines. Factors potentially related to magnitude and durability of response include age, time, and vaccine reactogenicity. This study analyzed SARS-CoV-2 IgG spike antibody responses following the second dose of vaccine in healthcare workers (HCWs). Data were collected from participants enrolled in a longitudinal SARS-CoV-2 serology study over a 12-month period. Participants completed a survey documenting symptoms post-vaccination. Serum specimens were tested for SARS-CoV-2 IgG antibodies using the Abbott Architect AdvisdeDx SARS-CoV-2 IgGII assay. Antibody levels were compared against time from second vaccine dose, and symptoms following vaccination. Altogether, 335 women (86.6%) and 52 men (13.4%) participated. Median age was 37 years (IQR 30-43). Overall median antibody level was 2150.80 [1246.12, 3556.98] AU/mL (IQR). Age was not associated with antibody concentration (<i>p</i>-value = 0.10). Higher antibody responses (2253 AU/mL vs. 1506 AU/mL; <i>p</i> = 0.008) were found in HCWs with one or more symptoms after the second dose of the vaccine (n = 311). Antibody responses persisted throughout the study period post-vaccination; statistically significant decreases in antibody responses were observed over time (<i>p</i> < 0.001). Higher antibody response was associated with reactogenicity post-vaccine. Age and sex were not associated with higher antibody responses.https://www.mdpi.com/2076-393X/10/4/601SARS-CoV-2vaccine reactionsantibody measurement
spellingShingle Jane A. Dickerson
Janet A. Englund
Xing Wang
Julie C. Brown
Danielle M. Zerr
Bonnie Strelitz
Eileen J. Klein
Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination
Vaccines
SARS-CoV-2
vaccine reactions
antibody measurement
title Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination
title_full Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination
title_fullStr Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination
title_full_unstemmed Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination
title_short Higher Antibody Concentrations in U.S. Health Care Workers Associated with Greater Reactogenicity Post-Vaccination
title_sort higher antibody concentrations in u s health care workers associated with greater reactogenicity post vaccination
topic SARS-CoV-2
vaccine reactions
antibody measurement
url https://www.mdpi.com/2076-393X/10/4/601
work_keys_str_mv AT janeadickerson higherantibodyconcentrationsinushealthcareworkersassociatedwithgreaterreactogenicitypostvaccination
AT janetaenglund higherantibodyconcentrationsinushealthcareworkersassociatedwithgreaterreactogenicitypostvaccination
AT xingwang higherantibodyconcentrationsinushealthcareworkersassociatedwithgreaterreactogenicitypostvaccination
AT juliecbrown higherantibodyconcentrationsinushealthcareworkersassociatedwithgreaterreactogenicitypostvaccination
AT daniellemzerr higherantibodyconcentrationsinushealthcareworkersassociatedwithgreaterreactogenicitypostvaccination
AT bonniestrelitz higherantibodyconcentrationsinushealthcareworkersassociatedwithgreaterreactogenicitypostvaccination
AT eileenjklein higherantibodyconcentrationsinushealthcareworkersassociatedwithgreaterreactogenicitypostvaccination